Children's Hospital Los Angeles, citing recent U.S. Food and Drug Administration actions, on Monday said it has paused usage of Sarepta Therapeutics' gene therapy Elevidys in all patients with ...

H.C. Wainwright sets a rare $0 target for Sarepta Therapeutics amid FDA scrutiny over its Duchenne muscular dystrophy gene therapy Elevidys. Read more here.

A Cambridge-based company developing gene therapies for rare diseases is laying off more than a third of its workforce.

The company will pause several gene therapy development programs, for which it intends to seek partners and other strategic alternatives.

The company aims to focus on high-impact programmes to meet its 2027 financial obligations and support long-term viability.

Sarepta Therapeutics is laying off 500 staffers, or 36% of its workforce, as part of a strategic restructuring aiming to save $400 million annually. | Sarepta Therapeutics has laid off 500 staffers, ...

Investing.com -- Sarepta Therapeutics (NASDAQ: SRPT) stock soared 36% in after-hours trading Wednesday after the biotech company announced a major strategic restructuring plan designed to ensure ...

Companies are removing entry-level jobs as AI takes over ...

The tech company is laying off 4% of its workforce worldwide, in the latest round of job cuts after slashing 6,000 jobs in May.

National Taxpayer Advocate rings warning bell about how much the IRS will be prepared for 2026 tax season, given job cuts and tax changes.

More than 250 Virginia jobs are being cut in June, including layoffs at CarParts.com, Kroger, and Nakupuna Companies.

Indian River County public schools are seeing across-the-board academic improvement, even as the district moves forward with job cuts and leadership changes.